CMPX vs MOS · $367.4M cap vs P/E 161, rev $11.12B
Compass Therapeutics Inc. (CMPX) versus The Mosaic Company (MOS) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
CMPX does not have a complete income-statement cache yet.
Latest reported MOS revenue for 2024-12-31 was $11.12B. Net income was $202.0M. Revenue was down 18.8% from 2023-12-31 to 2024-12-31. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
CMPX currently screens at market cap $367.4M. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
Not investment advice. Open the CMPX and MOS stock pages for the full models.
Not investment advice.